The post-market study is a prospective, multi-center, single-arm, real world study of the Caterpillar Arterial Embolization Device. Enrollment will continue until up to fifty (50) subjects have been treated with the Caterpillar Arterial Embolization Device at up to 20 investigational sites in the United States.

